MAA
MDCO

Managed Account Advisors’s Medicines Co MDCO Stock Holding History

Managed Account Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$3.5M Buy
122,212
+6,705
+6% +$187K ﹤0.01% 1589
2015
Q1 		$3.24M Buy
115,507
+114,536
+11,796% +$3.22M ﹤0.01% 1635
2014
Q4 		$27K Buy
971
+403
+71% +$9.98K ﹤0.01% 2514
2014
Q3 		$13K Buy
568
+242
+74% +$6.15K ﹤0.01% 2596
2014
Q2 		$9K Sell
326
-26,749
-99% -$714K ﹤0.01% 2582
2014
Q1 		$769K Sell
27,075
-1,674
-6% -$55.4K ﹤0.01% 2019
2013
Q4 		$1.11M Buy
28,749
+2,396
+9% +$85.7K ﹤0.01% 1895
2013
Q3 		$883K Sell
26,353
-13,281
-34% -$423K ﹤0.01% 1913
2013
Q2 		$1.22M Buy
+39,634
New +$1.33M ﹤0.01% 1804

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Managed Account Advisors's MDCO Position: Q2 2015 in Review

Managed Account Advisors increased its Medicines Co (MDCO) stake by 5.8% in Q2 2015, buying an estimated $187K and bringing the position to 122,212 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Managed Account Advisors first reported a position in MDCO in Q2 2013 and has held it in 9 quarters since. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

  • Managed Account Advisors held 122,212 shares of Medicines Co worth $3.5M as of Q2 2015.
  • Managed Account Advisors bought 6,705 Medicines Co shares in Q2 2015, an estimated $187K.
  • Medicines Co made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1589 holding.
  • Managed Account Advisors first reported a position in Medicines Co in Q2 2013 and has held it in 9 quarters since.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.